This website uses cookies, pixels, and similar technologies (“cookies”), some of which are provided by third parties, to enable website features and functionality; measure, analyze, and improve site performance; enhance user experience; record user interactions; and support our advertising and marketing. We and our third-party vendors may monitor, record, and access information and data, including device data, IP address and online identifiers, referring URLs and other browsing information, for these and similar purposes. By clicking “Accept all cookies,” you agree to such purposes. If you continue to browse our site without clicking “Accept all cookies,” or if you click “Reject all cookies,” only cookies necessary to operate and enable default website features and functionalities will be deployed. If you are visiting our Site in the U.S., by using this site or clicking “Accept all cookies,” “Reject all cookies,” or “Preferences,” you acknowledge and agree to our Privacy Policy, Cookie Policy, and Terms of Use.

library

IQT News
/
No items found.

Outlier Announces Automated Business Analysis Platform for Government Agencies

Read the Paper

In-Q-Tel, Inc. Investment and Strategic Partnership Advances Company Growth by Allowing U.S. Intelligence Agencies to Take Advantage of Outlier's Platform to Better Understand Time-Series Data Through Automated Analysis

May 14, 2019

Outlier, a pioneer in Automated Business Analysis, today announced a strategic partnership and an investment from In-Q-Tel, Inc. (IQT). IQT is the not-for-profit strategic investor that identifies and accelerates the delivery of innovative technology solutions to support the mission of the U.S. intelligence and defense agencies that keep our nation safe. This strategic partnership reinforces that Outlier is a leader in Automated Business Analysis. It further validates the company's artificial intelligence platform in supporting the operational requirements of U.S. government agencies for analysis of cloud-based and on-premise data sets.

"Outlier's platform takes a differentiated approach to leveraging artificial intelligence to surface unexpected patterns and changes in time-series data, which can enable agencies to make informed decisions more quickly," said Divya Sudhakar, Principal, Investments at IQT. "Outlier has proven a unique ability to provide high fidelity insights without requiring users to commit significant time and resources to analyze their data."

"Being chosen by IQT is a major milestone for Outlier and confirms the effectiveness of our Automated Business Analysis platform," said Sean Byrnes, Co-Founder and CEO of Outlier. "We expect this partnership and other government partnerships to address the need to analyze billions of data points daily and present stories that will help enhance national security."

About Outlier

Outlier identifies unexpected changes across business data so that marketing, data scientists and analysts can make more informed decisions quickly. As an Automated Business Analysis platform, Outlier discovers hidden patterns and relationships that are impossible to find manually with artificial intelligence and machine learning algorithms. Adding any integration only takes minutes, and each integration helps global organizations learn more about different aspects of their business. Most recently, Outlier was named a 2018 Cool Vendor in Analytics by Gartner for being innovative, intriguing, and impactful1, honored as one of CRN's "The Coolest Business Analytics Companies" of the 2019 Big Data 100, and took first place honors during the Pharmaceutical R&D Information Systems Management Executives Forum (PRISME Forum).

_______________________

1Gartner does not endorse any vendor, product or service depicted by its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

No items found.